Back to discover
Disease
Hematoma
Late-stage therapeutic developmentEmerging research
2
Publications
18
Clinical trials
2023
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2023-07-19Stroke
Research2014-08-29European heart journal
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Moderate
Key developments
- 4 clinical trials expected to report results, the earliest in Q4 2026.
Upcoming Milestones
- Q4 2026Prospective Clinical Investigation on Infection as a Cause of Chronic Subdural Hematoma.
- Q1 2027TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma
- Q4 2028Randomized Trial Comparing Adjuvant Tranexamic Acid Versus Surgery Alone For Chronic Subdural Hematoma
- Q2 2032Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy
Major developments
Upcoming trial readoutHigh impact
Results expected Q1 20272026-05-29
Upcoming trial readoutHigh impact
Results expected Q4 20262026-04-29
Clinical MilestonesViewHide
Results posted
Results expected
- 2026-06-04Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming MastectomyResults expected Q2 2032
- 2026-05-29TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural HematomaResults expected Q1 2027
- 2026-04-29Prospective Clinical Investigation on Infection as a Cause of Chronic Subdural Hematoma.Results expected Q4 2026
- 2025-12-08Randomized Trial Comparing Adjuvant Tranexamic Acid Versus Surgery Alone For Chronic Subdural HematomaResults expected Q4 2028
Activity timeline5
- 2026-06-04ClinicalInvestigating the Use of Intravenous Tranexamic Acid in Gender Affirming MastectomyResults expected Q2 2032
- 2026-05-29ClinicalTRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural HematomaResults expected Q1 2027
- 2026-04-29ClinicalProspective Clinical Investigation on Infection as a Cause of Chronic Subdural Hematoma.Results expected Q4 2026
- 2025-12-08ClinicalRandomized Trial Comparing Adjuvant Tranexamic Acid Versus Surgery Alone For Chronic Subdural HematomaResults expected Q4 2028
- 2025-11-26ClinicalA Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast SurgeryResults posted
Clinical trials
The current development programme across all trial phases.
Clinical programme
18
6
15
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20142023
Most influential
Recent publications
Major themes4
- Aorta, Abdominal1
- Aorta, Thoracic1
- Chemokine CX3CL11
- Infant, Newborn, Diseases1
Leading journals2
- European heart journal1
- Stroke1
Leading researchers8
- Aboyans V1
- Allmen RS1
- Bartolomeo RD1
- Boileau C1
- Bossone E1
- Chen X1
- Dong S1
- Eggebrecht H1
Affiliations (unnormalised)6
- Department of Neurosurgery and Brain and Nerve Research Laboratory (Y.Z.)1
- First Affiliated Hospital of Soochow University1
- Institute for Fetology (P.Z.)1
- Loma Linda University School of Medicine1
- School of Medicine1
- Zhujiang Hospital1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.